Evenamide: A Potential Pharmacotherapeutic Alternative for Treatment-Resistant Schizophrenia
Int J Neuropsychopharmacol
.
2024 Feb 1;27(2):pyae005.
doi: 10.1093/ijnp/pyae005.
Authors
Raghunath Singh
1
,
Margaret K Hahn
1
2
3
4
,
Yashika Bansal
5
,
Sri Mahavir Agarwal
1
2
3
4
,
Gary Remington
1
2
3
Affiliations
1
Schizophrenia Division, the Centre for Addiction and Mental Health, Toronto, ON, Canada.
2
Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
3
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
4
Banting and Best Diabetes Centre, University of Toronto, Toronto, ON, Canada.
5
Neurobiology of Depression and Aging Lab, the Centre for Addiction and Mental Health, Toronto, ON, Canada.
PMID:
38195245
PMCID:
PMC10858345
DOI:
10.1093/ijnp/pyae005
No abstract available
MeSH terms
Antipsychotic Agents* / therapeutic use
Humans
Schizophrenia* / drug therapy
Schizophrenia, Treatment-Resistant
Substances
Antipsychotic Agents